Diosmin was administered intraperitoneally 11 times from day 0 to day 15 (Figure 9A), after which brain tumor development was evaluated using an in vivo imaging system (IVIS), H&S and Ki67 staining. The gene discussed is MKI67; the disease is brain neoplasm.